Nicotine and Microvascular Responses in Skeletal Muscle from Acute Exposure to Cigarettes and Vaping
Open Access
- 16 June 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (12) , 10208
Abstract
Despite claims of safety or harm reduction for electronic cigarettes (E-cig) use (also known as vaping), emerging evidence indicates that E-cigs are not likely safe, or necessarily safer than traditional cigarettes, when considering the user’s risk of developing vascular dysfunction/disease. E-cigs are different from regular cigarettes in that E-cig devices are highly customizable, and users can change the e-liquid composition (such as the base solution, flavors, and nicotine level). Since the effects of E-cigs on the microvascular responses in skeletal muscle are poorly understood, we used intravital microscopy with an acute (one-time 10 puff) exposure paradigm to evaluate the individual components of e-liquid on vascular tone and endothelial function in the arterioles of the gluteus maximus muscle of anesthetized C57Bl/6 mice. Consistent with the molecular responses seen with endothelial cells, we found that the peripheral vasoconstriction response was similar between mice exposed to E-cig aerosol or cigarette smoke (i.e., 3R4F reference cigarette); this response was not nicotine dependent, and endothelial cell-mediated vasodilation was not altered within this acute exposure paradigm. We also report that, regardless of the base solution component [i.e., vegetable glycerin (VG)-only or propylene glycol (PG)-only], the vasoconstriction responses were the same in mice with inhalation exposure to 3R4F cigarette smoke or E-cig aerosol. Key findings from this work reveal that some component other than nicotine, in inhaled smoke or aerosol, is responsible for triggering peripheral vasoconstriction in skeletal muscle, and that regardless of one’s preference for an E-cig base solution composition (i.e., ratio of VG-to-PG), the acute physiological response to blood vessels appears to be the same. The data suggest that vaping is not likely to be ‘safer’ than smoking towards blood vessels and can be expected to produce and/or result in the same adverse vascular health outcomes associated with smoking cigarettes.Keywords
Funding Information
- WVU Cancer Institute (IMO)
- Marshall University/West Virginia University Health Collaborative Grant (IMO)
This publication has 65 references indexed in Scilit:
- Levels of selected carcinogens and toxicants in vapour from electronic cigarettesTobacco Control, 2013
- Inhaled nickel nanoparticles alter vascular reactivity in C57BL/6 miceInhalation Toxicology, 2010
- Ageing and vascular ageingPostgraduate Medical Journal, 2006
- Effects of theatrical smokes and fogs on respiratory health in the entertainment industryAmerican Journal of Industrial Medicine, 2005
- Reactive Oxygen Species in the VasculatureHypertension, 2003
- Cardiovascular Toxicity of Nicotine: Implications for Nicotine Replacement Therapy 11All editorial decisions for this article, including selection of referees, were made by a Guest Editor. This policy applies to all articles with authors from the University of California San Francisco.JACC, 1997
- The Safety of Transdermal Nicotine as an Aid to Smoking Cessation in Patients with Cardiac DiseaseNew England Journal of Medicine, 1996
- The cardiovascular pathology of smokingAmerican Heart Journal, 1988
- Effects of nicotine and its major metabolites on blood pressure in anaesthetized ratsJournal of Molecular Medicine, 1985
- Cardiac Effects of Intracoronary Arterial Injections of NicotineCirculation Research, 1958